Kane Biotech Inc. (CVE:KNE – Get Free Report) shares traded up 16.7% on Wednesday . The company traded as high as C$0.05 and last traded at C$0.04. 1,598,050 shares traded hands during mid-day trading, an increase of 1,209% from the average session volume of 122,121 shares. The stock had previously closed at C$0.03.
Kane Biotech Stock Up 16.7%
The company has a quick ratio of 0.39, a current ratio of 0.80 and a debt-to-equity ratio of -331.42. The firm has a market capitalization of C$5.82 million, a PE ratio of -0.39 and a beta of 0.29. The business’s 50-day moving average price is C$0.04 and its 200-day moving average price is C$0.04.
About Kane Biotech
Kane Biotech Inc, a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, an antimicrobial wound gel platform; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine for treating wounds and otic infections.
Further Reading
- Five stocks we like better than Kane Biotech
- The Significance of Brokerage Rankings in Stock Selection
- Why Consumers Are Abandoning Chipotle, Sweetgreen and Cava
- How to Read Stock Charts for Beginners
- Apple Stock Could Surge on Record iPhone Sales and Bold AI Strategy
- Find and Profitably Trade Stocks at 52-Week Lows
- Dividend Growth Is Heating Up: 3 Stocks With Steady Payout Gains
Receive News & Ratings for Kane Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kane Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
